{
  "paper_id": "PMC9520444",
  "url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9520444/",
  "figures": {
    "figure_1": {
      "figure_number": "Figure 1",
      "title": "Figure 1.  Time to First Skin Cancer Since Organ Transplant.",
      "caption": "",
      "possible_urls": [
        [
          "original_src",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6cf1/9520444/eb917356208a/jamadermatol-e223878-g001.jpg"
        ],
        [
          "large_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6cf1/9520444/eb917356208a/jamadermatol-e223878-g001.jpg?maxwidth=2000"
        ],
        [
          "original_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6cf1/9520444/eb917356208a/jamadermatol-e223878-g001.jpg?size=original"
        ],
        [
          "xlarge_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6cf1/9520444/eb917356208a/jamadermatol-e223878-g001.jpg?maxwidth=4000"
        ]
      ],
      "figure_id": "doi220051f1",
      "is_table": false,
      "working_url": "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6cf1/9520444/eb917356208a/jamadermatol-e223878-g001.jpg",
      "download_success": true,
      "local_image_path": "./data/PMC9520444/images/figure_1.jpg",
      "final_url": "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6cf1/9520444/eb917356208a/jamadermatol-e223878-g001.jpg"
    },
    "figure_2": {
      "figure_number": "Figure 2",
      "title": "Figure 2.  Time to Second Skin Cancer Since First Skin Cancer Among Organ Transplant Recipients.",
      "caption": "",
      "possible_urls": [
        [
          "original_src",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6cf1/9520444/83d3b6bf2c27/jamadermatol-e223878-g002.jpg"
        ],
        [
          "large_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6cf1/9520444/83d3b6bf2c27/jamadermatol-e223878-g002.jpg?maxwidth=2000"
        ],
        [
          "original_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6cf1/9520444/83d3b6bf2c27/jamadermatol-e223878-g002.jpg?size=original"
        ],
        [
          "xlarge_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6cf1/9520444/83d3b6bf2c27/jamadermatol-e223878-g002.jpg?maxwidth=4000"
        ]
      ],
      "figure_id": "doi220051f2",
      "is_table": false,
      "working_url": "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6cf1/9520444/83d3b6bf2c27/jamadermatol-e223878-g002.jpg",
      "download_success": true,
      "local_image_path": "./data/PMC9520444/images/figure_2.jpg",
      "final_url": "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6cf1/9520444/83d3b6bf2c27/jamadermatol-e223878-g002.jpg"
    },
    "figure_3": {
      "figure_number": "Figure 3",
      "title": "Figure 3.  Time to Third Skin Cancer Since Second Skin Cancer Among Organ Transplant Recipients.",
      "caption": "",
      "possible_urls": [
        [
          "original_src",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6cf1/9520444/cc871fca5268/jamadermatol-e223878-g003.jpg"
        ],
        [
          "large_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6cf1/9520444/cc871fca5268/jamadermatol-e223878-g003.jpg?maxwidth=2000"
        ],
        [
          "original_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6cf1/9520444/cc871fca5268/jamadermatol-e223878-g003.jpg?size=original"
        ],
        [
          "xlarge_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6cf1/9520444/cc871fca5268/jamadermatol-e223878-g003.jpg?maxwidth=4000"
        ]
      ],
      "figure_id": "doi220051f3",
      "is_table": false,
      "working_url": "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6cf1/9520444/cc871fca5268/jamadermatol-e223878-g003.jpg",
      "download_success": true,
      "local_image_path": "./data/PMC9520444/images/figure_3.jpg",
      "final_url": "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6cf1/9520444/cc871fca5268/jamadermatol-e223878-g003.jpg"
    }
  },
  "claims": [
    {
      "sentence": "No. of skin cancers\nPatients, No. (%)\n\n\nSkin cancer after transplant (n = 5129)\nNo skin cancer at baseline (n = 5077)\nSkin cancer at baseline (n = 52)\n\n\n\n\n0\n4434 (86.4)\n4434 (100)\n0\n\n\n1-3\n318 (6.2)\n298 (93.7)\n20 (6.3)\n\n\n4-9\n192 (3.7)\n176 (91.7)\n16 (8.3)\n\n\n≥10\n185 (3.6)\n169 (91.4)\n16 (8.6)\n\n\n\nOpen in a new tabRates of Skin Cancer Development by Transplanted Organ Type\nPatients with liver transplants developed a first skin cancer after transplant at a lower rate compared with heart, lung, or kidney recipients (χ2 test, 25.6; df, 4; P < .001) (Figure 1A).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "Panel A",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "Panel A",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "After the development of a first skin cancer, patients were far more likely to develop a second and third skin cancer than to experience the competing risk of death (Figure 2 and Figure 3).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "Open in a new tabRates of Skin Cancer Development by Age at Transplant\nAfter transplant, there was a steady increase in the risk of first skin cancer risk among all age groups (Figure 1B).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "Panel B",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "Panel B",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Among patients who survived to develop a second skin cancer, there was very low mortality, and nearly 100% went on to develop a third skin cancer across all organ types and all transplant age groups (Figure 3).Voriconazole Exposure\nA total of 318 patients had posttransplant exposure to voriconazole, 190 of whom were lung recipients.",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "No. of skin cancers\nPatients, No. (%)\n\n\nSkin cancer after transplant (n = 5129)\nNo skin cancer at baseline (n = 5077)\nSkin cancer at baseline (n = 52)\n\n\n\n\n0\n4434 (86.4)\n4434 (100)\n0\n\n\n1-3\n318 (6.2)\n298 (93.7)\n20 (6.3)\n\n\n4-9\n192 (3.7)\n176 (91.7)\n16 (8.3)\n\n\n≥10\n185 (3.6)\n169 (91.4)\n16 (8.6)\n\n\n\nOpen in a new tabRates of Skin Cancer Development by Transplanted Organ Type\nPatients with liver transplants developed a first skin cancer after transplant at a lower rate compared with heart, lung, or kidney recipients (χ2 test, 25.6; df, 4; P < .001) (Figure 1A).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "Panel A",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "Panel A",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "After the development of a first skin cancer, patients were far more likely to develop a second and third skin cancer than to experience the competing risk of death (Figure 2 and Figure 3).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "Open in a new tabRates of Skin Cancer Development by Age at Transplant\nAfter transplant, there was a steady increase in the risk of first skin cancer risk among all age groups (Figure 1B).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "Panel B",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "Panel B",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Among patients who survived to develop a second skin cancer, there was very low mortality, and nearly 100% went on to develop a third skin cancer across all organ types and all transplant age groups (Figure 3).Voriconazole Exposure\nA total of 318 patients had posttransplant exposure to voriconazole, 190 of whom were lung recipients.",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "No. of skin cancers\nPatients, No. (%)\n\n\nSkin cancer after transplant (n = 5129)\nNo skin cancer at baseline (n = 5077)\nSkin cancer at baseline (n = 52)\n\n\n\n\n0\n4434 (86.4)\n4434 (100)\n0\n\n\n1-3\n318 (6.2)\n298 (93.7)\n20 (6.3)\n\n\n4-9\n192 (3.7)\n176 (91.7)\n16 (8.3)\n\n\n≥10\n185 (3.6)\n169 (91.4)\n16 (8.6)\n\n\n\nOpen in a new tabRates of Skin Cancer Development by Transplanted Organ Type\nPatients with liver transplants developed a first skin cancer after transplant at a lower rate compared with heart, lung, or kidney recipients (χ2 test, 25.6; df, 4; P < .001) (Figure 1A).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "Panel A",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "Panel A",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "After the development of a first skin cancer, patients were far more likely to develop a second and third skin cancer than to experience the competing risk of death (Figure 2 and Figure 3).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "Open in a new tabRates of Skin Cancer Development by Age at Transplant\nAfter transplant, there was a steady increase in the risk of first skin cancer risk among all age groups (Figure 1B).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "Panel B",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "Panel B",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Among patients who survived to develop a second skin cancer, there was very low mortality, and nearly 100% went on to develop a third skin cancer across all organ types and all transplant age groups (Figure 3).Voriconazole Exposure\nA total of 318 patients had posttransplant exposure to voriconazole, 190 of whom were lung recipients.",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "No. of skin cancers\nPatients, No. (%)\n\n\nSkin cancer after transplant (n = 5129)\nNo skin cancer at baseline (n = 5077)\nSkin cancer at baseline (n = 52)\n\n\n\n\n0\n4434 (86.4)\n4434 (100)\n0\n\n\n1-3\n318 (6.2)\n298 (93.7)\n20 (6.3)\n\n\n4-9\n192 (3.7)\n176 (91.7)\n16 (8.3)\n\n\n≥10\n185 (3.6)\n169 (91.4)\n16 (8.6)\n\n\n\nOpen in a new tabRates of Skin Cancer Development by Transplanted Organ Type\nPatients with liver transplants developed a first skin cancer after transplant at a lower rate compared with heart, lung, or kidney recipients (χ2 test, 25.6; df, 4; P < .001) (Figure 1A).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "Panel A",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "Panel A",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "After the development of a first skin cancer, patients were far more likely to develop a second and third skin cancer than to experience the competing risk of death (Figure 2 and Figure 3).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "Open in a new tabRates of Skin Cancer Development by Age at Transplant\nAfter transplant, there was a steady increase in the risk of first skin cancer risk among all age groups (Figure 1B).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "Panel B",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "Panel B",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Among patients who survived to develop a second skin cancer, there was very low mortality, and nearly 100% went on to develop a third skin cancer across all organ types and all transplant age groups (Figure 3).Voriconazole Exposure\nA total of 318 patients had posttransplant exposure to voriconazole, 190 of whom were lung recipients.",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "No. of skin cancers\nPatients, No. (%)\n\n\nSkin cancer after transplant (n = 5129)\nNo skin cancer at baseline (n = 5077)\nSkin cancer at baseline (n = 52)\n\n\n\n\n0\n4434 (86.4)\n4434 (100)\n0\n\n\n1-3\n318 (6.2)\n298 (93.7)\n20 (6.3)\n\n\n4-9\n192 (3.7)\n176 (91.7)\n16 (8.3)\n\n\n≥10\n185 (3.6)\n169 (91.4)\n16 (8.6)\n\n\n\nOpen in a new tabRates of Skin Cancer Development by Transplanted Organ Type\nPatients with liver transplants developed a first skin cancer after transplant at a lower rate compared with heart, lung, or kidney recipients (χ2 test, 25.6; df, 4; P < .001) (Figure 1A).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "Panel A",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "Panel A",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "After the development of a first skin cancer, patients were far more likely to develop a second and third skin cancer than to experience the competing risk of death (Figure 2 and Figure 3).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "Open in a new tabRates of Skin Cancer Development by Age at Transplant\nAfter transplant, there was a steady increase in the risk of first skin cancer risk among all age groups (Figure 1B).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "Panel B",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "Panel B",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Among patients who survived to develop a second skin cancer, there was very low mortality, and nearly 100% went on to develop a third skin cancer across all organ types and all transplant age groups (Figure 3).Voriconazole Exposure\nA total of 318 patients had posttransplant exposure to voriconazole, 190 of whom were lung recipients.",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "No. of skin cancers\nPatients, No. (%)\n\n\nSkin cancer after transplant (n = 5129)\nNo skin cancer at baseline (n = 5077)\nSkin cancer at baseline (n = 52)\n\n\n\n\n0\n4434 (86.4)\n4434 (100)\n0\n\n\n1-3\n318 (6.2)\n298 (93.7)\n20 (6.3)\n\n\n4-9\n192 (3.7)\n176 (91.7)\n16 (8.3)\n\n\n≥10\n185 (3.6)\n169 (91.4)\n16 (8.6)\n\n\n\nOpen in a new tabRates of Skin Cancer Development by Transplanted Organ Type\nPatients with liver transplants developed a first skin cancer after transplant at a lower rate compared with heart, lung, or kidney recipients (χ2 test, 25.6; df, 4; P < .001) (Figure 1A).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "Panel A",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "Panel A",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "After the development of a first skin cancer, patients were far more likely to develop a second and third skin cancer than to experience the competing risk of death (Figure 2 and Figure 3).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "Open in a new tabRates of Skin Cancer Development by Age at Transplant\nAfter transplant, there was a steady increase in the risk of first skin cancer risk among all age groups (Figure 1B).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "Panel B",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "Panel B",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Among patients who survived to develop a second skin cancer, there was very low mortality, and nearly 100% went on to develop a third skin cancer across all organ types and all transplant age groups (Figure 3).Voriconazole Exposure\nA total of 318 patients had posttransplant exposure to voriconazole, 190 of whom were lung recipients.",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "No. of skin cancers\nPatients, No. (%)\n\n\nSkin cancer after transplant (n = 5129)\nNo skin cancer at baseline (n = 5077)\nSkin cancer at baseline (n = 52)\n\n\n\n\n0\n4434 (86.4)\n4434 (100)\n0\n\n\n1-3\n318 (6.2)\n298 (93.7)\n20 (6.3)\n\n\n4-9\n192 (3.7)\n176 (91.7)\n16 (8.3)\n\n\n≥10\n185 (3.6)\n169 (91.4)\n16 (8.6)\n\n\n\nOpen in a new tabRates of Skin Cancer Development by Transplanted Organ Type\nPatients with liver transplants developed a first skin cancer after transplant at a lower rate compared with heart, lung, or kidney recipients (χ2 test, 25.6; df, 4; P < .001) (Figure 1A).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "Panel A",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "Panel A",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "After the development of a first skin cancer, patients were far more likely to develop a second and third skin cancer than to experience the competing risk of death (Figure 2 and Figure 3).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "Open in a new tabRates of Skin Cancer Development by Age at Transplant\nAfter transplant, there was a steady increase in the risk of first skin cancer risk among all age groups (Figure 1B).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "Panel B",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "Panel B",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Among patients who survived to develop a second skin cancer, there was very low mortality, and nearly 100% went on to develop a third skin cancer across all organ types and all transplant age groups (Figure 3).Voriconazole Exposure\nA total of 318 patients had posttransplant exposure to voriconazole, 190 of whom were lung recipients.",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "No. of skin cancers\nPatients, No. (%)\n\n\nSkin cancer after transplant (n = 5129)\nNo skin cancer at baseline (n = 5077)\nSkin cancer at baseline (n = 52)\n\n\n\n\n0\n4434 (86.4)\n4434 (100)\n0\n\n\n1-3\n318 (6.2)\n298 (93.7)\n20 (6.3)\n\n\n4-9\n192 (3.7)\n176 (91.7)\n16 (8.3)\n\n\n≥10\n185 (3.6)\n169 (91.4)\n16 (8.6)\n\n\n\nOpen in a new tabRates of Skin Cancer Development by Transplanted Organ Type\nPatients with liver transplants developed a first skin cancer after transplant at a lower rate compared with heart, lung, or kidney recipients (χ2 test, 25.6; df, 4; P < .001) (Figure 1A).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "Panel A",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "Panel A",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "After the development of a first skin cancer, patients were far more likely to develop a second and third skin cancer than to experience the competing risk of death (Figure 2 and Figure 3).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "Open in a new tabRates of Skin Cancer Development by Age at Transplant\nAfter transplant, there was a steady increase in the risk of first skin cancer risk among all age groups (Figure 1B).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "Panel B",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "Panel B",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Among patients who survived to develop a second skin cancer, there was very low mortality, and nearly 100% went on to develop a third skin cancer across all organ types and all transplant age groups (Figure 3).Voriconazole Exposure\nA total of 318 patients had posttransplant exposure to voriconazole, 190 of whom were lung recipients.",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "No. of skin cancers\nPatients, No. (%)\n\n\nSkin cancer after transplant (n = 5129)\nNo skin cancer at baseline (n = 5077)\nSkin cancer at baseline (n = 52)\n\n\n\n\n0\n4434 (86.4)\n4434 (100)\n0\n\n\n1-3\n318 (6.2)\n298 (93.7)\n20 (6.3)\n\n\n4-9\n192 (3.7)\n176 (91.7)\n16 (8.3)\n\n\n≥10\n185 (3.6)\n169 (91.4)\n16 (8.6)\n\n\n\nOpen in a new tabRates of Skin Cancer Development by Transplanted Organ Type\nPatients with liver transplants developed a first skin cancer after transplant at a lower rate compared with heart, lung, or kidney recipients (χ2 test, 25.6; df, 4; P < .001) (Figure 1A).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "Panel A",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "Panel A",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "After the development of a first skin cancer, patients were far more likely to develop a second and third skin cancer than to experience the competing risk of death (Figure 2 and Figure 3).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "Open in a new tabRates of Skin Cancer Development by Age at Transplant\nAfter transplant, there was a steady increase in the risk of first skin cancer risk among all age groups (Figure 1B).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "Panel B",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "Panel B",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Among patients who survived to develop a second skin cancer, there was very low mortality, and nearly 100% went on to develop a third skin cancer across all organ types and all transplant age groups (Figure 3).Voriconazole Exposure\nA total of 318 patients had posttransplant exposure to voriconazole, 190 of whom were lung recipients.",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "Rates of Skin Cancer Development by Transplanted Organ Type\nPatients with liver transplants developed a first skin cancer after transplant at a lower rate compared with heart, lung, or kidney recipients (χ2 test, 25.6; df, 4; P < .001) (Figure 1A).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "Panel A",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "Panel A",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "After the development of a first skin cancer, patients were far more likely to develop a second and third skin cancer than to experience the competing risk of death (Figure 2 and Figure 3).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "Patients with liver transplants developed a first skin cancer after transplant at a lower rate compared with heart, lung, or kidney recipients (χ2 test, 25.6; df, 4; P < .001) (Figure 1A).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "Panel A",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "Panel A",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "After the development of a first skin cancer, patients were far more likely to develop a second and third skin cancer than to experience the competing risk of death (Figure 2 and Figure 3).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "Rates of Skin Cancer Development by Age at Transplant\nAfter transplant, there was a steady increase in the risk of first skin cancer risk among all age groups (Figure 1B).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "Panel B",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "Panel B",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Among patients who survived to develop a second skin cancer, there was very low mortality, and nearly 100% went on to develop a third skin cancer across all organ types and all transplant age groups (Figure 3).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "After transplant, there was a steady increase in the risk of first skin cancer risk among all age groups (Figure 1B).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "Panel B",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "Panel B",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Among patients who survived to develop a second skin cancer, there was very low mortality, and nearly 100% went on to develop a third skin cancer across all organ types and all transplant age groups (Figure 3).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    }
  ],
  "extraction_stats": {
    "figures_count": 3,
    "claims_count": 44,
    "images_downloaded": 3,
    "tables_filtered": 49
  }
}